FDA clears Elekta's radiotherapy planning system:
This article was originally published in Clinica
Executive Summary
Elekta Oncology Systems has received US FDA 510(k) clearance for its PrecisePLAN radiotherapy planning system. The system provides efficient tools and the ability to visualise in three-dimensions complex conformal and stereotactic techniques used to treat cancer, said the Crawley, UK company.